Healthbox Innovation Day

Tute investor and board member Dr. Dinesh Patel, and Tute CEO Reid Robison, addressed the crowd at the Healthbox Innovation Day event on Thursday about how genomics is transforming medicine. “Pretty soon every doctor will be a geneticist, because genome-guided medicine is here,” said Dr. Robison. “The cost of sequencing the human genome has dropped … Continue reading Healthbox Innovation Day

MEDSCAPE.COM: Genomic Entrepreneurs Promise to Personalize Medicine

Laird Harrison September 26, 2014 SANTA CLARA, California — The era of personalized medicine continues to advance with the introduction of products that can analyze genes, developers report. “Eventually, everyone will have their genome sequenced,” said Reid Robison, MD, MBA, from Tute Genomics. “Imagine a world in which your medical care is 100% unique. Every diagnosis, every … Continue reading MEDSCAPE.COM: Genomic Entrepreneurs Promise to Personalize Medicine

Tute selected as one of top 10 most promising digital health startups of 2014, presenting at Health 2.0’s Startup Championship

Traction: Health 2.0’s Startup Championship‘s 10 finalists were just announced, with Tute Genomics featured as one of the top 10 most promising digital health startups of 2014. Tute CEO Dr. Reid Robison will be presenting at the Traction: Startup Championship on Monday September 22nd in Santa Clara, CA at the Health 2.0 Conference. See here for … Continue reading Tute selected as one of top 10 most promising digital health startups of 2014, presenting at Health 2.0’s Startup Championship

Bio Investor Forum

Tute Genomics’ Chief Executive Officer, Reid Robison, has been selected to present as part of the Discovery Track at the 2014 BIO Investor Forum. http://www.businesswire.com/news/home/20140825005937/en/13th-Annual-BIO-Investor-Forum-Host-100#.U_4vLmSwKa5  

Hero Partners

Tute Genomics is participating in Hero Partners retreat on the sunflower model. Tute will be presenting its core competencies including: 1) Built on the expertise underlying ANNOVAR, which has >850 citations and is used in more gene discovery studies than any other technology. 2) Powering the worlds genetic knowledge with an unprecedented genetic variant database of over 20 … Continue reading Hero Partners

ASHG 2014

Tute Genomics will be exhibiting as well as presenting a poster titled “A Novel Family-based Approach for Analysis and Interpretation of Exome Sequencing Data in Pedigrees” at ASHG. http://ashg.org/2014meeting/

Health 2.0

Tute Genomics has been selected to demo its clinical genome interpretation platform as part of the “Tools for Digital Diagnosis” breakout session at the upcoming Health 2.0 conference. http://www.health2con.com/events/conferences/health-2-0-fall-conference-2014/